What is the management plan for a patient with right eye disc hemorrhages, collaterals, few dots, and retinal nerve fiber layer (RNFL) hemorrhages, with possible periphlebitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Right Eye Disc Hemorrhages with Collaterals, RNFL Hemorrhages, and Possible Periphlebitis

This presentation requires urgent comprehensive evaluation to differentiate between glaucomatous optic neuropathy (which demands immediate IOP-lowering intervention) versus vascular occlusive disease or inflammatory periphlebitis (which may require entirely different management including systemic workup and anti-inflammatory therapy).

Immediate Diagnostic Priorities

Rule Out Glaucoma First

  • Measure intraocular pressure immediately using Goldmann applanation tonometry before any gonioscopy or pupil dilation, as disc hemorrhages are strongly associated with glaucomatous progression 1
  • The presence of disc hemorrhages increases the risk of developing primary open-angle glaucoma from 5.2% to 13.6% over 8 years, and these hemorrhages herald focal disc damage and visual field loss 1
  • Perform gonioscopy to exclude angle closure or secondary causes of IOP elevation such as angle neovascularization, inflammatory precipitates, or peripheral anterior synechiae 1
  • Document central corneal thickness, as thin corneas (<555 μm) may underestimate true IOP and increase glaucoma risk 1

Evaluate for Vascular Occlusive Disease

  • The presence of collateral vessels is highly concerning for retinal vascular occlusion or ischemic syndrome and is NOT a typical feature of glaucoma 2
  • Obtain fluorescein angiography urgently to assess for retinal ischemia, neovascularization, capillary non-perfusion, or inflammatory vascular leakage consistent with periphlebitis 2
  • Consider cerebral vascular imaging if moyamoya disease or other cerebrovascular stenosis is suspected, particularly if there are bilateral findings or systemic symptoms 2

Assess for Inflammatory Periphlebitis

  • Examine for anterior chamber inflammation including cells, flare, keratic precipitates, or posterior synechiae that would support uveitic periphlebitis 1
  • Look for vitreous cells or haze on dilated examination 1
  • If periphlebitis is confirmed, initiate systemic workup for inflammatory causes including sarcoidosis, tuberculosis, syphilis, and autoimmune conditions

Structural Documentation

Optic Nerve Assessment

  • Document optic nerve appearance using stereoscopic slit-lamp biomicroscopy through a dilated pupil, looking specifically for vertical cup elongation, rim thinning (especially inferior/superior), notching, and violation of the ISNT rule 1, 3
  • Obtain color stereophotography to document disc hemorrhages and baseline nerve appearance, as this is the accepted standard for qualitative documentation 1
  • Perform OCT imaging of the optic nerve head, RNFL, and macula to quantify structural damage and establish baseline for progression monitoring 1
  • Note that disc hemorrhages do NOT artifactually alter OCT vessel density or RNFL thickness measurements, so scans obtained with hemorrhages present are valid 4

Visual Field Testing

  • Obtain baseline standard automated perimetry (SAP) using 24-2 or 30-2 testing strategy to detect functional deficits, as structural changes may precede or follow visual field loss 1
  • Consider 10-2 testing if central field involvement is suspected 1
  • Repeat any newly detected glaucomatous defects to confirm the change before making treatment decisions 1

Management Algorithm

If Glaucoma is Diagnosed (Elevated IOP + Structural Changes)

  • Initiate IOP-lowering therapy immediately with a target IOP at least 20-30% below baseline, as disc hemorrhages signify ongoing optic nerve damage and high progression risk 1
  • Monitor closely every 2-3 months initially, as patients with disc hemorrhages require more aggressive follow-up 1
  • Adjust target IOP lower if any progression is detected on repeat imaging or visual field testing 1

If Vascular Occlusive Disease is Confirmed

  • Refer urgently to retina specialist for consideration of anti-VEGF therapy if neovascularization is present 2
  • Initiate systemic vascular workup including carotid imaging, cardiac evaluation, and hematologic assessment for hypercoagulable states
  • Consider panretinal photocoagulation if extensive ischemia with neovascularization is documented 2

If Inflammatory Periphlebitis is Confirmed

  • Initiate systemic corticosteroids after infectious etiologies are excluded
  • Coordinate care with rheumatology or infectious disease for underlying systemic disease management
  • Monitor for treatment response with serial fluorescein angiography

Critical Pitfalls to Avoid

  • Do not assume this is benign isolated disc hemorrhage without comprehensive evaluation, as the presence of collaterals suggests more serious vascular pathology 2
  • Isolated peripapillary hemorrhages in crowded/tilted discs of myopic patients may be benign and self-resolving, but this diagnosis requires exclusion of glaucoma, neovascular membranes, and disc edema first 5
  • Do not delay fluorescein angiography if collaterals are present, as this finding is atypical for primary glaucoma and suggests ischemic or inflammatory disease 2
  • Disc hemorrhages in glaucoma patients indicate higher risk of progression and warrant more aggressive IOP lowering, not observation alone 1, 3
  • The combination of dots (likely hemorrhages) and RNFL hemorrhages suggests either severe glaucomatous damage or multilevel vascular compromise requiring urgent intervention 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Glaucoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Asymptomatic peripapillary subretinal hemorrhage: a study of 10 cases.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.